期刊
CANCER TREATMENT REVIEWS
卷 101, 期 -, 页码 -出版社
ELSEVIER SCI LTD
DOI: 10.1016/j.ctrv.2021.102227
关键词
Immunotherapy; Cold tumors; Hot tumors; Inflamed tumors; Tumor microenvironment
类别
Immune checkpoint inhibitors have revolutionized cancer treatment, but many patients still do not respond to these therapies. By examining the immune phenotypes in the tumor microenvironment, researchers aim to predict patient-specific responses. Strategies to reprogram the tumor microenvironment are being explored to enhance the efficacy of immunotherapies, along with combinations with other therapeutic options.
Immune checkpoint inhibitors have revolutionized the treatment landscape for a number of cancers over the last few decades. Nevertheless, a majority of patients still do not benefit from these treatments. Such patient-specific lack of response can be predicted, in part, from the immune phenotypes present in the tumor microenvironment. We provide a perspective on options to reprogram the tumors and their microenvironment to increase the therapeutic efficacy of immunotherapies and expand their efficacy against cold tumors. Additionally, we review data from current preclinical and clinical trials aimed at testing the different therapeutic options in monotherapy or preferably in combination with checkpoint inhibitors.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据